Carducci MA - Search Results

1

Acetylation and histone deacetylase inhibitors in cancer.

Kortenhorst MS, Carducci MA, Shabbeer S. Kortenhorst MS, et al. Among authors: carducci ma. Cell Oncol. 2006;28(5-6):191-222. doi: 10.1155/2006/760183. Cell Oncol. 2006. PMID: 17167175 Free PMC article. Review. No abstract available.

2

A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors.

Kortenhorst MS, Zahurak M, Shabbeer S, Kachhap S, Galloway N, Parmigiani G, Verheul HM, Carducci MA. Kortenhorst MS, et al. Among authors: carducci ma. Clin Cancer Res. 2008 Nov 1;14(21):6886-94. doi: 10.1158/1078-0432.CCR-08-0119. Clin Cancer Res. 2008. PMID: 18980983 Free PMC article.

3

Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.

Kortenhorst MS, Wissing MD, Rodríguez R, Kachhap SK, Jans JJ, Van der Groep P, Verheul HM, Gupta A, Aiyetan PO, van der Wall E, Carducci MA, Van Diest PJ, Marchionni L. Kortenhorst MS, et al. Among authors: carducci ma. Epigenetics. 2013 Sep;8(9):907-20. doi: 10.4161/epi.25574. Epub 2013 Jul 19. Epigenetics. 2013. PMID: 23880963 Free PMC article.

4

Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

Wissing MD, Mendonca J, Kortenhorst MS, Kaelber NS, Gonzalez M, Kim E, Hammers H, van Diest PJ, Carducci MA, Kachhap SK. Wissing MD, et al. Among authors: carducci ma. FASEB J. 2013 Oct;27(10):4279-93. doi: 10.1096/fj.12-222893. Epub 2013 Jul 24. FASEB J. 2013. PMID: 23884428 Free PMC article.

5

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.

Paller CJ, Wissing MD, Mendonca J, Sharma A, Kim E, Kim HS, Kortenhorst MS, Gerber S, Rosen M, Shaikh F, Zahurak ML, Rudek MA, Hammers H, Rudin CM, Carducci MA, Kachhap SK. Paller CJ, et al. Among authors: carducci ma. Cancer Med. 2014 Oct;3(5):1322-35. doi: 10.1002/cam4.289. Epub 2014 Jul 3. Cancer Med. 2014. PMID: 24989836 Free PMC article.

6

Focus on deacetylation for therapeutic benefit.

Shabbeer S, Carducci MA. Shabbeer S, et al. Among authors: carducci ma. IDrugs. 2005 Feb;8(2):144-54. IDrugs. 2005. PMID: 15696416 Review.

7

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.

Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA. Shabbeer S, et al. Among authors: carducci ma. Prostate. 2007 Jul 1;67(10):1099-110. doi: 10.1002/pros.20587. Prostate. 2007. PMID: 17477369

8

Mechanism of growth inhibition of prostate cancer xenografts by valproic acid.

Sidana A, Wang M, Shabbeer S, Chowdhury WH, Netto G, Lupold SE, Carducci M, Rodriguez R. Sidana A, et al. J Biomed Biotechnol. 2012;2012:180363. doi: 10.1155/2012/180363. Epub 2012 Oct 2. J Biomed Biotechnol. 2012. PMID: 23093837 Free PMC article.

9

Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.

Xia Q, Sung J, Chowdhury W, Chen CL, Höti N, Shabbeer S, Carducci M, Rodriguez R. Xia Q, et al. Cancer Res. 2006 Jul 15;66(14):7237-44. doi: 10.1158/0008-5472.CAN-05-0487. Cancer Res. 2006. PMID: 16849572

10

Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.

Kortenhorst MS, Isharwal S, van Diest PJ, Chowdhury WH, Marlow C, Carducci MA, Rodriguez R, Veltri RW. Kortenhorst MS, et al. Among authors: carducci ma. Mol Cancer Ther. 2009 Apr;8(4):802-8. doi: 10.1158/1535-7163.MCT-08-1076. Mol Cancer Ther. 2009. PMID: 19372553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page